Are you James H. Raybourn, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileJames H. Raybourn, M.D. practices urology in Greenwood, IN. James is a 2009 graduate of Indiana University School of Medicine. James is also listed as specializing in student in an organized health care education program. Medicare claims data shows James provided 14,232 services to 4,053 patients. The services billed most often include injection, denosumab, 1 mg, leuprolide injectable, camcevi, 1 mg, and psa (prostate specific antigen) measurement, total. The provider's National Provider Identifier (NPI) is 1871736595.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
679 E COUNTY LINE RD
Greenwood, IN 46143
Within Urology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Bladder and urethra
Kidney and ureter
Male reproductive and sexual health
Prostate
Urinary symptoms and infection
Bladder & Urination
Kidney health
Men's health
Urinary symptoms
Most searched procedures
Office diagnosis
Bladder procedures
Diagnostic imaging
Kidney & ureter procedures
Kidney and ureter surgery
Male reproductive
Prostate
Prostate procedures
Stone procedures
14,232 services · 4,053 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Diagnostic exam of bladder and urethra using an endoscope | Procedure | 52000 |
74 | As often as other peers in Urology |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96402 |
127 | More than most peers in Urology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
108 | More often than most peers in Urology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
7,440 | More often than most peers in Urology |
| Leuprolide injectable, camcevi, 1 mg | Drug given | J1952 |
1,134 | More often than most peers in Urology |
| Leuprolide acetate (for depot suspension), 7.5 mg | Drug given | J9217 |
375 | More than most peers in Urology |
| Injection, ceftriaxone sodium, per 250 mg | Drug given | J0696 |
132 | More often than most peers in Urology |
| Psa (prostate specific antigen) measurement, total | Lab test | 84153 |
808 | More than most peers in Urology |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Office visit | 99214 |
667 | More often than most peers in Urology |
| Bacterial colony count, urine | Lab test | 87086 |
572 | More than most peers in Urology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
James H. Raybourn is an urologist in Greenwood, IN. That is the designation recorded for this NPI in the federal registry, where it is listed as “Urology”.
NPI registry
James H. Raybourn is listed at 679 E County Line Rd, Greenwood, IN 46143. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (317) 859-7222. Contact the office directly to confirm availability and scheduling.
NPI registry
James H. Raybourn's National Provider Identifier is 1871736595. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
James H. Raybourn attended Indiana University School of Medicine, graduating in 2009. This comes from the CMS National Downloadable File.
CMS public data
James H. Raybourn has 17 years experience. Calculated from a graduation year of 2009, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, James H. Raybourn performs procedures including diagnostic exam of bladder and urethra using an endoscope; provides treatments such as administration of hormonal anti-neoplastic chemotherapy under skin or into muscle and injection of drug or substance under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by James H. Raybourn. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.